Kintara Therapeutics Inc (KTRA)

[jssdmm]

Watching from the sidelines may be a wise move. The promise of this drug is evident, but there has been NO traction on price but for once when it went to $9. I've communicated to management about the trials, etc. and they say they are on track. The surprise that MAY catch people off guard is if any preliminary results are announced. The FDA has it on fast track and as a salvage treatment perhaps they approve early. That said, this won't happen any time soon. Still just enrolling. That said, a $300 million valuation (not that much) would put this over $22. We shall see. The last leg is here so its a matter of financing and efficacy now. Do keep an eye on it though.

There is a presentation that will be live online this monday the 11th for DMPI. See news.

I will investigate VBLT. Thanks.